Literature DB >> 10203714

Would suicide gene therapy solve the 'T-cell dilemma' of allogeneic bone marrow transplantation?

J L Cohen1, O Boyer, D Klatzmann.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10203714     DOI: 10.1016/s0167-5699(98)01420-0

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


× No keyword cloud information.
  4 in total

Review 1.  Improving the safety of cell therapy with the TK-suicide gene.

Authors:  Raffaella Greco; Giacomo Oliveira; Maria Teresa Lupo Stanghellini; Luca Vago; Attilio Bondanza; Jacopo Peccatori; Nicoletta Cieri; Sarah Marktel; Sara Mastaglio; Claudio Bordignon; Chiara Bonini; Fabio Ciceri
Journal:  Front Pharmacol       Date:  2015-05-05       Impact factor: 5.810

2.  Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model.

Authors:  Aude Burlion; Simon Brunel; Nicolas Y Petit; Daniel Olive; Gilles Marodon
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

Review 3.  Current Preventions and Treatments of aGVHD: From Pharmacological Prophylaxis to Innovative Therapies.

Authors:  Sina Naserian; Mathieu Leclerc; Sara Shamdani; Georges Uzan
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

4.  CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease.

Authors:  José L Cohen; Aurélie Trenado; Douglas Vasey; David Klatzmann; Benoît L Salomon
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.